Drug intelligence / Profile preview

amalian SF

Development stage
Unknown
Lead developer
S&V Technologies
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Intradermal, Subcutaneous
01

Overview

Amalian SF is a line of CE-marked monophasic hyaluronic acid dermal fillers designed for aesthetic medicine. These fillers are based on ultra-pure, fully hydrated hyaluronic acid gels produced via biofermentation and are free from animal components. The Amalian SF range includes products with varying concentrations and viscosities to address different cosmetic needs—from fine lines (e.g., Amalian SF 16 fine) to moderate wrinkles (e.g., Amalian SF 20 medium), deeper folds and volume augmentation (e.g., Amalian SF 24 advanced), and strong volumizing effects (e.g., Amalian SF 28 macro). The mechanism of action is physical volumization by space-occupying gel in the dermis or subcutaneous tissue; the product does not induce pharmacological changes but provides immediate lifting and smoothing effects that last from approximately six months up to a year depending on the specific product. All products are fully degradable by endogenous hyaluronidases. Developed in Germany by S&V Technologies, these fillers meet high safety standards for biocompatibility and sterility[1][3][5][8].

Brand names
amalian SFAMALIAN SF 20 mediumAMALIAN SF 16 fineAMALIAN SF 24 advancedAMALIAN SF 28 macro
Other names
amalian Soft Fillermonophasic hyaluronic acid filler line

Beyond the preview

Go deeper on amalian SF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amalian SF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call